From: Efficacy and clinical outcome of the port-a-cath in children: a tertiary care-center experience
Group 1 (n = 164) | Group 2 (n = 404) | t/chi-square | p value | |
---|---|---|---|---|
Age (years) | 4.1 ± 3.5 | 5.5 ± 3.9 | − 3.95 | < 0.001 |
Male | 103 (62.8%) | 242 (59.9%) | 0.41 | 0.52 |
Diagnosis | 10.19 | 0.04 | ||
Hematological malignancy | 88 (53.7%) | 241 (59.7%) | ||
Solid organ malignancy | 49 (29.9%) | 94 (23.2%) | ||
Pure hematological disease | 4 (2.4%) | 27 (6.7%) | ||
Metabolic disease | 3 (1.8%) | 12 (3%) | ||
Others for poor vascular | 20 (12.2%) | 30 (7.4%) | ||
Access | ||||
Reason of insertion | 2.84 | 0.25 | ||
Chemotherapy | 141 (86%) | 357 (88.4%) | ||
Blood product | 1 (0.6%) | 0 | ||
Supplements | 22 (13.4%) | 47 (11.6%) | ||
Location of insertion | 568 | <0.001 | ||
Left external jugular | 136 (82.9%) | 0 | ||
Right external jugular | 28 (17.1%) | 0 | ||
Left subclavian | 0 | 203 (50.3%) | ||
Right subclavian | 0 | 65 (16.1%) | ||
Left internal jugular | 0 | 112 (27.7%) | ||
Right internal jugular | 0 | 22 (5.5%) | ||
Other | 0 | 2 (0.5%) | ||
Need central line before insertion | 59 (36%) | 143 (35.4%) | 0.017 | 0.9 |